RSS-Feed abonnieren
DOI: 10.1055/s-2005-915446
Neurosarkoidose
NeurosarcoidosisPublikationsverlauf
Publikationsdatum:
02. August 2006 (online)

Weiterbildungsziele In diesem Beitrag sollen folgende Weiterbildungsziele vermittelt werden: Überblick über den aktuellen Stand der Ätiopathogenese der Sarkoidose Epidemiologie der Neurosarkoidose mögliche klinische Manifestationen und typische Konstellationen der Neurosarkoidose mögliche und notwendige Diagnostik der Neurosarkoidose Therapie der Neurosarkoidose
Literatur
- 1 Zajicek J P. Neurosarcoidosis. Curr Opin Neurol. 2000; 13 323-325
- 2 Baughman R P, Lower E E, Bois R M du. Sarcoidosis. Lancet. 2003; 361 1111-1118
- 3 Stern B J. Neurological complications of sarcoidosis. Curr Opin Neurol. 2004; 17 311-316
- 4 Hoitsma E, Faber C G, Drent M, Sharma O P. Neurosarcoidosis: a clinical dilemma. Lancet Neurol. 2004; 3 397-407
- 5 Gullapalli D, Phillips 2nd L H. Neurosarcoidosis. Curr Neurol Neurosci Rep. 2004; 4 441-447
-
6 Crystal R G.
Sarcoidosis. In: Fauci AS, Braunwald E, Isselbacher KJ et al. (eds) Harrison's Principles of Internal Medicine, 14th ed. New York; McGraw-Hill 1998: 1922-1928 - 7 Lower E E, Broderick J P, Brott T G, Baughman R P. Diagnosis and management of neurological sarcoidosis. Arch Intern Med. 1997; 157 1864-1868
- 8 Sharma O P. Neurosarcoidosis. A personal perspective based on the study of 37 patients. Chest. 1997; 112 220-228
- 9 Vinas F C, Rengachary S. Diagnosis and management of neurosarcoidosis. J Clin Neurosci. 2001; 8 505-513
- 10 Zajicek J P, Scolding N J, Foster O. et al . Central nervous system sarcoidosis - diagnosis and management. Q J Med. 1999; 92 103-117
- 11 Iwai K, Tachibana T, Takemura T. et al . Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn. 1993; 43 372-376
- 12 Leiba H, Siatkowski R M, Culbertson W W, Glaser J S. Neurosarcoidosis presenting as an intracranial mass in childhood. J Neuroophthalmol. 1996; 16 269-273
- 13 Ng K L, McDermott N, Romanowski C A, Jackson A. Neurosarcoidosis masquerading as glioma of the optic chiasm in a child. Postgrad Med J. 1995; 71 265-268
- 14 Yamaguchi M, Hosoda Y, Sasaki R, Aoki K. Epidemiological study on sarcoidosis in Japan. Recent trends in incidence and prevalence rates and changes in epidemiological features. Sarcoidosis. 1989; 6 138-146
- 15 Hunninghake G W, Costabel U, Ando M. et al . ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999; 16 149-173
- 16 Hosoda Y, Sasagawa S, Yasuda N. Epidemiology of sarcoidosis: new frontiers to explore. Curr Opin Pulm Med. 2002; 8 424-428
-
17 Damian M S, Reichmann H.
Neurosarkoidose. In: Hopf C, Deuschl G, Diener HC, Reichmann H (Hrsg) Neurologie in Praxis und Klinik. 3., vollständig überarbeitete Auflage. Band I. Stuttgart, New York; Georg Thieme Verlag 1999: 881-886 - 18 Radziwill A, Weder B. Neurosarkoidose des zentralen Nervensystems. Analyse des Langzeitverlaufes in 8 Fällen. Nervenarzt. 1995; 66 915-922
- 19 Achiron L, Strominger M, Witkin N, Primo S. Sarcoid optic neuropathy: a case report. J Am Optom Assoc. 1995; 66 646-651
- 20 Krejchi D, Caldemeyer K S, Vakili S T, Pritz M B. Neurosarcoidosis resembling meningioma: MRI characteristics and pathologic correlation. J Neuroimaging. 1998; 8 177-179
- 21 O'Reilly B J, Burrows E H. VIIIth cranial nerve involvement in sarcoidosis. J Laryngol Otol. 1995; 109 1089-1093
- 22 Sugaya F, Shijubo N, Takahashi H, Abe S. Sudden hearing loss as the initial manifestation of neurosarcoidosis. Sarcoidosis Vasc Diffus Lung Dis. 1996; 13 54-56
- 23 Oki M, Takizawa S, Ohnuki Y, Shinohara Y. MRI findings of VIIth cranial nerve involvement in sarcoidosis. Br J Radiol. 1997; 70 859-861
- 24 Gizzi M S, Lidov M, Rosenbaum D. Neurosarcoidosis presenting as a tumour of the basal ganglia and brainstem: sequential MRI. Neurol Res. 1993; 15 93-96
- 25 Oksanen V. Neurosarcoidosis. Sarcoidosis. 1994; 11 76-79
- 26 Bona J R, Fackler S M, Fendley M J, Nemeroff C B. Neurosarcoidosis as a cause of refractory psychosis: a complicated case report. Am J Psychiatry. 1998; 155 1106-1108
- 27 Stubgen J P. Neurosarcoidosis presenting as a retroclival mass. Surg Neurol. 1995; 43 85-87
- 28 Maisel J A, Lynam T. Unexpected death in a young pregnant woman: unusual presentation of neurosarcoidosis. ANN Emerg Med. 1996; 28 94-97
- 29 Sato N, Sze G, Kim J H. Cystic pituary mass in neurosarcoidosis. Am J Neuroradiol. 1997; 18 1182-1185
- 30 Guoth M S, Kim J, Lotbiniere A C de, Brines M L. Neurosarcoidosis presenting as hypopituitarism and a cystic pituitary mass. Am J Med Sci. 1998; 315 220-224
- 31 Chapelon C, Ziza J M, Piette J C. et al . Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine. 1990; 69 261-276
- 32 Fried E D, Landau A J, Sher J H, Rao C. Spinal cord sarcoidosis: a case report and review of the literature. J Assoc Acad Minor Phys. 1993; 4 132-137
- 33 Ku A, Lachmann E, Tunkel R, Nagler W. Neurosarcoidosis of the conus medullaris and cauda equina presenting as paraparesis: case report and review of the literature. Paraplegia. 1996; 34 116-120
- 34 Abbrey L E, Rosenblum M K, Angelis L M de. Sarcoidosis of the cauda equina mimicking leptomeningeal malignancy. J Neurooncol. 1998; 39 261-265
- 35 Stjernberg N, Cajander S, Truedsson H, Uddenfeldt P. Muscle involvement in sarcoidosis. Acta Med Scand. 1981; 209 213-216
- 36 Dale J C, O'Brien J F. Determination of angiotensin-converting enzyme levels in cerebrospinal fluid is not a useful test for the diagnosis of neurosarcoidosis (letter). Mayo Clin Proc. 1999; 74 535
- 37 Tahmoush A J, Amir M S, Connor W W. et al . CSF-ACE activity in probable CNS neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2002; 19 191-197
- 38 Scott T F. Neurosarcoidosis: progress and clinical aspects. Neurology. 1993; 43 1-8
- 39 Worofka B, Lassmann J, Bauer K, Kristoferitsch W. Praktische Liquorzelldiagnostik 1. Auflage. Wien, New York; Springer-Verlag 1997
- 40 Lexa F J, Grossman R I. MR of sarcoidosis in the head and spine: spectrum of manifestations and radiographic response to steroid therapy. Am J Neuroradiology. 1994; 15 973-982
- 41 Sharma O P. Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement. Arch Neurol. 1998; 55 1248-1254
- 42 Sherman J L, Stern B J. Sarcoidosis of the CNS: Comparison of unenhanced and enhanced MR images. Am J Neuroradiology. 1990; 11 915-923
- 43 Salvage D R, Spencer J A, Batchelor A G. et al . Sarcoid involvement of the supraorbital nerve: MR and histologic findings. Am J Neuroradiol. 1997; 18 1785-1787
- 44 Sugita M, Sano M, Uchigata M. et al . Facial nerve enhancement on gadolinium-DTPA in a case with neurosarcoidosis. Intern Med. 1997; 36 825-828
- 45 Leu N H, Chen C Y, Wu C S. et al . Primary chiasmal sarcoid granuloma: MRI. Neuroradiology. 1999; 41 440-442
- 46 Duffey P, Bates D. Transient focal neurological deficit in sarcoidosis. Sarcoidosis Vasc Diffus Lung Dis. 1997; 14 171-172
- 47 Osborn A G, Tong K A. Handbook of Neuroradiology: Brain and Skull. Second edition. St. Louis; Mosby 1996
- 48 Maña J. Magnetic resonance imaging and nuclear imaging in sarcoidosis. Curr Opin Pulm Med. 2002; 8 457-463
- 49 Jackson R J, Goodman J C, Huston D P, Harper R L. Parafalcine and bilateral convexity neurosarcoidosis mimicking meningeoma: case report and review of the literature. Neurosurgery. 1998; 42 635-638
- 50 Agbogu B N, Stern B J, Sewell C, Yang G. Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol. 1995; 52 875-879
- 51 Stern B J, Schonfeld S A, Sewell C. et al . The treatment of neurosarcoidosis with cyclosporine. Arch Neurol. 1992; 49 1065-1072
- 52 Haraoui B. Differentiating the efficacy of the tumor necrosis factor inhibitors. Semin Arthritis Rheum. 2005; 34 (5, Suppl 1) 7-11
- 53 Pettersen J A, Zochodne D W, Bell R B. et al . Refractory neurosarcoidosis responding to infliximab. Neurology. 2002; 59 1660-1661
- 54 Morcos Z. Refractory neurosarcoidosis responding to infliximab. Neurology. 2003; 60 1220-1221
- 55 Carter J D, Valeriano J, Vasey F B, Bognar B. Refractory neurosarcoidosis: a dramatic response to infliximab. Am J Med. 2004; 117 277-279
- 56 Sollberger M, Fluri F, Baumann T. et al . Successful treatment of steroid-refractory neurosarcoidosis with infliximab. J Neurol. 2004; 251 760-761
- 57 Doty J D, Mazur J E, Judson M A. Treatment of sarcoidosis with infliximab. Chest. 2005; 127 1064-1071
- 58 Zabel P, Entzian P, Dalhoff K, Schlaak M. Pentoxifylline in treatment of sarcoidosis. Am J Respir Crit Care Med. 1997; 155 1665-1669
- 59 Walter M C, Lochmuller H, Schlotter-Weigel B. et al . Successful treatment of muscle sarcoidosis with thalidomide. Acta Myol. 2003; 22 22-25
- 60 Utz J P, Limper A H, Kalra S. et al . Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest. 2003; 124 177-185
- 61 Callejas-Rubio J L, Ortego-Centeno N, Lopez-Perez L, Benticuaga M N. Treatment of therapy-resistant sarcoidosis with adalimumab. Clin Rheumatol. 2005; 1 - 2 , [Epub ahead of print]
- 62 Kouba D J, Mimouni D, Rencic A, Nousari H C. Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis. Br J Dermatol. 2003; 148 147-148
- 63 Tikoo R K, Kupersmith M J, Finlay J L. Treatment of refractory neurosarcoidosis with cladribine. N Engl J Med. 2004; 350 1798-1799
Dr. med. E. Jacobasch
Universitätsklinikum Carl Gustav Carus · Klinik und Poliklinik für Neurologie
Fetscherstraße 74
01307 Dresden
eMail: eleonore.jacobasch@neuro.med.tu-dresden.de